Skip to main content
SpringerLink
Log in

Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity

  • Research Paper
  • Published:
Journal of Nanoparticle Research Aims and scope Submit manuscript

Abstract

Fullerenol C60(OH)24 with its spherical shape, symmetrical structure, 1 nm size and the ability to form polyionic nanoparticles in water solution, was used to synthesise a novel nanocomposite made of fullerenol nanoparticles (FNP) and iron ions (Fe2+). The FNP/Fe2+ nanocomposite was characterised by DLS and TEM-EDS analyses which have shown that the size distribution of FNP/Fe2+ stayed in the same scope as the size distribution of FNP, ranging from 11 to 60 nm. However, Fe2+ did affect the change of FNP’s zeta potential (− 49.2 mV), shifting it to more positive values (− 30.8 mV). In this study, it was assumed that FNP/Fe2+ could reduce the toxic effects of doxorubicin (Dox). Male Wistar rats were treated i.p. with FNP/Fe2+ nanocomposite 1 h prior to Dox treatment. At the subcellular level, the ultrastructural analysis revealed minor alterations sporadically displayed within the heart and liver tissues. Moreover, at the molecular level, the gene expressions analysis of mRNAs for catalase (heart and liver) and MnSOD (only liver) were significantly downregulated, indicating reduction in oxidative stress. Overall, the pretreatment with FNP/Fe2+ nanocomposite, followed by Dox application, significantly diminished harmful effects of the applied drug on the heart and liver, suggesting the potential protective effect of the nanocomposite on the healthy tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–437

    CAS  Google Scholar 

  • Alcolado R, Arthur MJP, Iredale JP (1997) Pathogenesis of liver fibrosis. Clin Sci 92:103–112

    CAS  Google Scholar 

  • Anderson R, Barron AR (2005) Reaction of hydroxyfullerene with metal salts: a route to remediation and immobilization. J Am Chem Soc 127:10458–10459

    CAS  Google Scholar 

  • Aryal B, Jeong J, Ashutosh Rao V (2014) Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity. Proc Natl Acad Sci 111:2011–2016

    CAS  Google Scholar 

  • Baimanov D, Cai R, Chen C (2019) Understanding the chemical nature of nanoparticle-protein interactions. Bioconjug Chem

  • Borović ML, Ičević I, Kanački Z, Žikić D, Seke M, Injac R, Djordjević A (2014) Effects of fullerenol C60(OH)24 nanoparticles on a single-dose doxorubicin-induced cardiotoxicity in pigs: an ultrastructural study. Ultrastruct Pathol 38:150–163

    Google Scholar 

  • Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, Li W, Liu J (2008) Polyhydroxylated fullerene derivative C60(OH)24 prevents mitochondrial dysfunction and oxidative damage in an MPP+-induced cellular model of Parkinson’s disease. J Neurosci Res 86:3622–3634

    CAS  Google Scholar 

  • Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16:3267–3285

    CAS  Google Scholar 

  • Chen M, von Mikecz A (2005) Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res 305:51–62

    CAS  Google Scholar 

  • Chen J, Rider DA, Ruan R (2006) Identification of valid housekeeping genes and antioxidant enzyme gene expression change in the aging rat liver. J Gerontol Ser A Biol Med Sci 61(2006):20–27

    Google Scholar 

  • Childs AC, Phaneuf SL, Dirks AJ, Phillips T, Leeuwenburgh C (2002) Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2: Bax ratio. Cancer Res 62:4592–4598

    CAS  Google Scholar 

  • Deavall DG, Martin EA, Horner JM, Roberts R (2012) Drug-induced oxidative stress and toxicity. J Toxicol 2012:645460

    Google Scholar 

  • Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF (2009) Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20:455101

    Google Scholar 

  • Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072

    CAS  Google Scholar 

  • Djordjević A, Vojinović-Miloradov M, Petranović N, Devečerski A, Lazar D, Ribar B (1998) Catalytic preparation and characterization of C60Br24. Fuller Sci Technol 6:689–694

    Google Scholar 

  • Djordjevic A, Canadanovic-Brunet J, Vojinovic-Miloradov M, Bogdanovic G (2005) Antioxidant properties and hypothetical radical mechanism of fullerol C60(OH)24. Oxid Commun 27:806–812

    Google Scholar 

  • Djordjevic A, Ajdinović B, Dopudja M, Trajkovic S, Milovanovic Z, Maksin T, Neskovic O, Bogdanović VB, Trpkov Djordje T, Cveticanin J (2011) Scintigraphy of the domestic dog using [Tc-99m(CO)(3)(H2O)(3)]-C-60(OH)(22-24). Dig J Nanomater Biostructures 6(2011):99–106

    Google Scholar 

  • Djordjevic A, Srdjenovic B, Seke M, Petrovic D, Injac R, Mrdjanovic J (2015) Review of synthesis and antioxidant potential of fullerenol nanoparticles. J Nanomater 16:280

    Google Scholar 

  • Đorđević AN, Ičević ID, Bogdanović VV (2009) Complex with fullerenol and copper (II). Hemijska Industrija 63:171–175

    Google Scholar 

  • Doroshow JH, Locker GY, Myers CE (1980) Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 65:128–135

    CAS  Google Scholar 

  • Dugan LL, Gabrielsen JK, Yu Shan P, Lin T-S, Choi DW (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 3:129–135

    CAS  Google Scholar 

  • Engin AB, Nikitovic D, Neagu M, Henrich-Noack P, Docea AO, Shtilman MI, Golokhvast K, Tsatsakis AM (2017) Mechanistic understanding of nanoparticles’ interactions with extracellular matrix: the cell and immune system. Part Fibre Toxicol 14:22

    Google Scholar 

  • Fonseca-Nunes, Ana, Paula Jakszyn, and Antonio Agudo. "Iron cancer risk-a systematic review and meta-analysis of the epidemiological evidence." Cancer epidemiology and prevention biomarkers 23 (2014): 12-31

  • Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577

    Google Scholar 

  • Goormaghtigh E, Chatelain P, Caspers J, Ruysschaert JM (1980) Evidence of a specific complex between adriamycin and negatively-charged phospholipids. Biochim Biophys Acta Biomembr 597:1–14

    CAS  Google Scholar 

  • Guenancia C, Li N, Hachet O, Rigal E, Cottin Y, Dutartre P, Rochette L, Vergely C (2015) Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice. Toxicol Appl Pharmacol 284:152–162

    CAS  Google Scholar 

  • Gutteridge JM (1984) Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron (III) complex. Biochem Pharmacol 33:1725–1728

    CAS  Google Scholar 

  • Haber F, Weiss J (1932) Über die katalyse des hydroperoxydes. Naturwissenschaften 20:948–950

    CAS  Google Scholar 

  • Heimann J, Morrow L, Anderson RE, Barron AR (2015) Understanding the relative binding ability of hydroxyfullerene to divalent and trivalent metals. Dalton Trans 44:4380–4388

    CAS  Google Scholar 

  • Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Prasad SV, Mutharasan RK, Naik TJ, Ardehali H (2014) Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest 124:617

    CAS  Google Scholar 

  • Injac R, Perse M, Obermajer N, Djordjevic-Milic V, Prijatelj M, Djordjevic A, Cerar A, Strukelj B (2008a) Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 29:3451–3460

    CAS  Google Scholar 

  • Injac R, Perse M, Boskovic M, Djordjevic-Milic V, Djordjevic A, Hvala A, Cerar A, Strukelj B (2008b) Cardioprotective effects of fullerenol C60(OH)24 on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm. Technol Cancer Res Treat 7:15–25

    CAS  Google Scholar 

  • Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B (2008c) Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenolC60(OH)24 via suppression of oxidative stress. Pharmacol Rep 60:742

    CAS  Google Scholar 

  • Injac R, Perse M, Cerne M, Potocnik N, Radic N, Govedarica B, Djordjevic A, Cerar A, Strukelj B (2009a) Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 30:1184–1196

    CAS  Google Scholar 

  • Injac R, Radic N, Govedarica B, Perse M, Cerar A, Djordjevic A, Strukelj B (2009b) Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenolC60(OH)24 through inhibition of oxidative stress. Pharmacol Rep 61:335–342

    CAS  Google Scholar 

  • Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, Dramicanin M et al (2006) Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 91:173–183

    CAS  Google Scholar 

  • Ji ZQ, Sun H, Wang H, Xie Q, Liu Y, Wang Z (2006) Biodistribution and tumor uptake of C60(OH)x in mice. J Nanopart Res 8:53–63

    CAS  Google Scholar 

  • Jović DS, Seke MN, Djordjevic AN, Mrđanović JZ, Aleksić LD, Bogdanović GM, Pavić AB, Plavec J (2016) Fullerenol nanoparticles as a new delivery system for doxorubicin. RSC Adv 6:38563–38578

    Google Scholar 

  • Koppenol WH (1993) The centennial of the Fenton reaction. Free Radic Biol Med 15:645–651

    CAS  Google Scholar 

  • Li T, Danelisen I, Belló-Klein A, Singal PK (2000) Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats. Cardiovasc Res 46:523–530

    CAS  Google Scholar 

  • Li Y, Luo HB, Zhang HY, Guo Q, Yao HC, Li JQ, Chang Q et al (2016) Potential hepatoprotective effects of fullerenol nanoparticles on alcohol-induced oxidative stress by ROS. RSC Adv 6:31122–31130

    CAS  Google Scholar 

  • Link G, Tirosh R, Pinson A, Hershko C (1996) Role of iron in the potentiation of anthracyclinecardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction. J Lab Clin Med 127:272–278

    CAS  Google Scholar 

  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25:402–408

    CAS  Google Scholar 

  • Manoli I, Alesci S, Blackman MR, Su YA, Rennert OM, Chrousos GP (2007) Mitochondria as key components of the stress response. Trends Endocrinol Metab 18:190–198

    CAS  Google Scholar 

  • Marzenell P, Hagen H, Sellner L, Zenz T, Grinyte R, Pavlov V, Daum S, Mokhir A (2013) Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells. J Med Chem 56:6935–6944

    CAS  Google Scholar 

  • Minotti G, Recalcati S, Mordente A, Liberi G, Calafiore AM, Mancuso C, Preziosi P, Cairo G (1998) The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J 12:541–552

    CAS  Google Scholar 

  • Minotti G, Ronchi R, Salvatorelli E, Menna P, Cairo G (2001) Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res 61:8422–8428

    CAS  Google Scholar 

  • Mirkov SM, Djordjevic AN, Andric NL, Andric SA, Kostic TS, Bogdanovic GM, Vojinovic-Miloradov MB, Kovacevic RZ (2004) Nitric oxide-scavenging activity of polyhydroxylatedfullerenol, C60(OH)24. Nitric Oxide 11:201–207

    CAS  Google Scholar 

  • Mobaraki M, Faraji A, Zare M, Dolati P, Ataei M, Dehghan Manshadi HR (2017) Molecular mechanisms of cardiotoxicity: a review on major side-effect of doxorubicin. Indian J Pharm Sci 79:335–344

    Google Scholar 

  • Moulin M, Piquereau J, Mateo P, Fortin D, Rucker-Martin C, Gressette M, Lefebvre F et al (2015) Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling. Circ Heart Fail 8:98–108

    CAS  Google Scholar 

  • Myers CE, Gianni L, Simone CB, Klecker R, Greene R (1982) Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin-iron complex. Biochemistry 21:1707–1713

    CAS  Google Scholar 

  • Olson RD, Mushlin PS, Brenner DE, Fleischer S, Cusack BJ, Chang BK, Boucek RJ (1988) Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci 85:3585–3589

    CAS  Google Scholar 

  • Parker MA, King V, Howard KP (2001) Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers. Biochim Biophys Acta Biomembr 1514:206–216

    CAS  Google Scholar 

  • Petrovic D, Seke M, Srdjenovic B, Djordjevic A (2015) Applications of anti/prooxidant fullerenes in nanomedicine along with fullerenes influence on the immune system. J Nanomater 16:279

    Google Scholar 

  • Petrovic D, Seke M, Labudovic Borovic M, Jovic D, Borisev I, Srdjenovic B, Rakocevic Z, Pavlovic V, Djordjevic A (2018) Hepatoprotective effect of fullerenol/doxorubicin nanocomposite in acute treatment of healthy rats. Exp Mol Pathol 104:199–211

    CAS  Google Scholar 

  • Pradhan A, Pinheiro JP, Seena S, Pascoal C, Cássio F (2014) Polyhydroxyfullerene binds cadmium ions and alleviates metal-induced oxidative stress in Saccharomyces cerevisiae. Appl Environ Microbiol 80:5874–5881

    Google Scholar 

  • Seke M, Petrovic D, Djordjevic A, Jovic D, Labudovic Borovic M, Kanacki Z, Jankovic M (2016) Fullerenol/doxorubicin nanocomposite mitigates acute oxidative stress and modulates apoptosis in myocardial tissue. Nanotechnology 27:485101

    Google Scholar 

  • Siddiqi S, Sussman MA (2014) The heart: mostly postmitotic or mostly premitotic? Myocyte cell cycle, senescence, and quiescence. Can J Cardiol 30:1270–1278

    Google Scholar 

  • Slavic M, Djordjevic A, Radojicic R, Milovanovic S, Orescanin-Dusic Z, Rakocevic Z, Spasic MB, Blagojevic D (2013) Fullerenol C60(OH)24 nanoparticles decrease relaxing effects of dimethyl sulfoxide on rat uterus spontaneous contraction. J Nanopart Res 15:1650

    Google Scholar 

  • Srdjenovic B, Milic-Torres V, Grujic N, Stankov K, Djordjevic A, Vasovic V (2010) Antioxidant properties of fullerenol C60(OH)24 in rat kidneys, testes, and lungs treated with doxorubicin. Toxicol Mech Methods 20:298–305

    CAS  Google Scholar 

  • Sugino N, Telleria CM, Gibori G (1998) Differential regulation of copper-zinc superoxide dismutase and manganese superoxide dismutase in the rat corpus luteum: induction of manganese superoxide dismutase messenger ribonucleic acid by inflammatory cytokines. Biol Reprod 59:208–215

    CAS  Google Scholar 

  • Swain K, Yusuf MY, Kalender S (2005) Doxorubicin hepatotoxicity and hepatic free radical metabolism in rats: the effects of vitamin E and catechin. Toxicology 209:39–45

    Google Scholar 

  • Ta HT, Li Z, Hagemeyer CE, Cowin G, Zhang S, Palasubramaniam J, Alt K, Wang X, Peter K, Whittaker AK (2017) Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast. Biomaterials 134:31–42

    CAS  Google Scholar 

  • Theil, Elisabeth C.,Gunther L.Eichhorn, and Luigi G. Morzilli. "Iron bindingproteins without cofactors or sulfur clusters."" Advances in inorganic biochemistry 5 (1983): 1-38

  • Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB (2011) Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics 21:440

    CAS  Google Scholar 

  • Torres VM, Srdjenovic B, Jacevic V, Dragojevic Simic V, Djordjevic A, Simplício AL (2010) Fullerenol C60(OH)24 prevents doxorubicin-induced acute cardiotoxicity in rats. Pharmacol Rep 62:707–718

    CAS  Google Scholar 

  • Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13:342

    CAS  Google Scholar 

  • Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710–717

    Google Scholar 

  • Wang Z, Gao X, Zhao Y (2018) Mechanisms of Antioxidant Activities of Fullerenols from First-Principles Calculation. J Phys Chem A 122:8183–8190

    CAS  Google Scholar 

  • Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE (2006) Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807

    CAS  Google Scholar 

  • Yagmurca M, Bas O, Mollaoglu H, Sahin O, Nacar A, Karaman O, Songur A (2007) Protective effects of erdosteine on doxorubicin-induced hepatotoxicity in rats. Arch Med Res 38:380–385

    CAS  Google Scholar 

  • Yang F, Teves SS, Kemp CJ, Henikoff S (2014) Doxorubicin, DNA torsion, and chromatin dynamics. Biochim Biophys Acta Rev Cancer 1845:84–89

    CAS  Google Scholar 

  • Yang L-Y, Gao J-L, Gao T, Dong P, Ma L, Jiang F-L, Liu Y (2016) Toxicity of polyhydroxylated fullerene to mitochondria. J Hazard Mater 301:119–126

    CAS  Google Scholar 

Download references

Acknowledgements

This work has received a financial support from the Ministry of Education, Science and Technological Development, Republic of Serbia, Grant No. III 45005.We thank Professor Vladimir Srdic (Faculty of Technology, University of Novi Sad, Serbia) for DLS measurements and MSc Ivana Andjelkovic for technical support.

Author information

Author notes

  1. Mariana Seke and Danijela Petrovic contributed equally to this work.

Authors and Affiliations

  1. Institute of Nuclear Sciences “Vinca”, University of Belgrade, Belgrade, Serbia

    Mariana Seke, Mirjana Novakovic & Zlatko Rakocevic

  2. Department of Natural Sciences and Management in Education, Faculty of Education Sombor, University of Novi Sad, Novi Sad, Serbia

    Danijela Petrovic

  3. Institute of Histology and Embryology “AleksandarDj. Kostic”, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

    Milica Labudovic Borovic

  4. Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, Novi Sad, Serbia

    Ivana Borisev & Aleksandar Djordjevic

Authors
  1. Mariana Seke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Danijela Petrovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Milica Labudovic Borovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ivana Borisev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mirjana Novakovic
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zlatko Rakocevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aleksandar Djordjevic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Mariana Seke or Danijela Petrovic.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seke, M., Petrovic, D., Labudovic Borovic, M. et al. Fullerenol/iron nanocomposite diminishes doxorubicin-induced toxicity. J Nanopart Res 21, 239 (2019). https://doi.org/10.1007/s11051-019-4681-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11051-019-4681-4

Keywords

Search

Navigation